Cytoprotective effects of phenolic acids on methylglyoxal-induced apoptosis in Neuro-2A cells

Molecular Nutrition and Food Research

Volumn 52, Issue 8, 2008, Pages 940-949

  Huang, Shang Ming ^a   Chuang, Hong Chih ^a   Wu, Chi Hao ^a   Yen, Gow Chin ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Cytoprotection; Glycation; Methylglyoxal; Neuro 2A cells; Phenolic acids

Indexed keywords

CASPASE 3; CHLOROGENIC ACID; DRUG DERIVATIVE; GALLIC ACID; HYDROXYBENZOIC ACID DERIVATIVE; LACTATE DEHYDROGENASE; METHYLGLYOXAL; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHENOLIC ACID; PROTEIN BCL 2; SYRINGIC ACID; VANILLIC ACID;

ANIMAL; APOPTOSIS; ARTICLE; CELL PROTECTION; CELL SURVIVAL; DIABETIC NEUROPATHY; DRUG EFFECT; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NEUROBLASTOMA; PATHOLOGY; SECRETION; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; CASPASE 3; CELL LINE, TUMOR; CELL SURVIVAL; CHLOROGENIC ACID; CYTOPROTECTION; DIABETIC NEUROPATHIES; GALLIC ACID; HYDROXYBENZOIC ACIDS; L-LACTATE DEHYDROGENASE; MAP KINASE SIGNALING SYSTEM; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; NEUROBLASTOMA; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS C-BCL-2; PYRUVALDEHYDE; VANILLIC ACID;

EID: 54549094837     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200700360     Document Type: Article

References (38)

1. Singh, R., Barden, A., Mori, T., Beilin, L., Advanced glycation end-products: a review, Diabetologia 2001, 44, 129-146.
2. Chellan, P., Nagaraj, R. H., Protein crosslinking by the Maillard reaction: dicarbonyl-derived imidazolium crosslinks in aging and diabetes, Arch. Biochem. Biophys. 1999, 368, 98-104.
3. Uchida, K., Khor, O. T., Oya, T., Osawa, T., et al., Protein modification by a Maillard reaction intermediate methylglyoxal. Immunochemical detection of fluorescent 5-methylimidazolone derivatives in vivo, FEBS Lett. 1997, 410, 313-318.
4. Brownlee, M., Biochemistry and molecular cell biology of diabetic complications, Nature 2001, 414, 813-820.
5. Wong, A., Luth, H. J., Arendt, T., Munch, G., Advanced glycation endproducts co-localize with inducible nitric oxide synthase in Alzheimer's disease, Brain Res. 2001, 920, 32-40.
6. Picklo Sr, M. J., Montine, T. J., Amarnath, V., et al., Carbonyl toxicology and alzheimer's disease, Toxicol. Appl. Pharmacol. 2002, 184, 187-197.
7. Hail, G. M., Jr., Lo, T. W., Thornalley, P. J., Methylglyoxal concentration and glyoxalase activities in the human lens, Exp. Eye Res. 1994, 59, 497-500.
8. Abordo, E. A., Minhas, H. S., Thornalley, P. J., Accumulation of alpha-oxoaldehydes during oxidative stress: a role in cytotoxicity. Biochem. Pharmacol. Biochem. Pharmacol. 1999, 58, 641-648.
9. Thornally, P. J., Jahan, I., Ng, R., Suppression of the accumulation of triosephosphates and increased formation of methylglyoxal in human red blood cells during hyperglycaemia by thiamine in vitro, J. Biochem. 2001, 129, 543-549.
10. Thornalley, P. J., The glyoxalase system in health and disease, Mol. Aspects Med. 1993, 419, 287-371.
11. Du, J., Suzuki, H., Nagase, F. A., Akhand, A., et al., Methylglyoxal induces apoptosis in Jurkat leukemia cells by activating c-Jun N-terminal kinase, Cell Biochem. 2000, 77, 333-44.
12. Sima, A. A., Sugimoto, K., Experimental diabetic neuropathy: an update, Diabetologia 1999, 42, 773-788.
13. de Arriba, S. G., Krugel, U., Ralf, R., Vissiennon, Z., et al., Carbonyl stress and NMDA receptor activation contribute to methylglyoxal neurotoxicity, Free Radic. Biol. Med. 2006, 40, 779-790.
14. Fukunaga, M., Miyata, S., Higo, S., Hamada, Y., et al., Methylglyoxal induces apoptosis through oxidative stress-mediated activation of p38 mitogen-activated protein kinase in rat Schwann cells, Ann. NY Acad. Sci. 2005, 1043, 151-157.
15. Nardini, M., Pisu, P., Gentili, V., Natella, F., Di, M., et al., Effect of caffeic acid on tert-butyl hydroperocide-induced ocidative stress in U937, Free Radical. Biol. Med. 1998, 25, 1098-1105.
16. Lodovici, M., Guglielmi, F., Meoni, M., Dolara, P., Effect of natural phenolic acids on DNA oxidation in vitro, Food Chem. Toxicol. 2001, 39, 1205-1210.
17. Bradford, M. M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem. 1976, 72, 248-254.
18. Hsieh, C. L., Yen, G. C., Chen, H. Y., Antioxidant activities of phenolic acids on ultraviolet radiation-induced erythrocyte and low density lipoprotein oxidation, J. Agric. Food Chem. 2005, 53, 6151-6155.
19. Yeh, C. T., Yen, G. C., Induction of hepatic antioxidant enzymes by phenolic acids in rats is accompanied by increased levels of multidrug resistance-associated protein 3 mRNA expression, J. Nutr. 2006, 136, 11-15.
20. Thornalley, P. J., Westwood, M., Lo, T. W., McLellan, A. C., Formation of methylglyoxal-modified proteins in vitro and in vivo and their involvement in AGE-related processes, Contrib. Nephrol. 1995, 112, 24-31.
21. Thornalley, P. J., Pharmacology of methylglyoxal, Gen. Pharmacol. 1996, 27, 565-573.
22. Thornalley, P. J., Langborg, A., Minhas, H. S., Formation of glyoxal, methylglyoxal and 3-DG in the glycation of protein, Biochem. J. 1999, 344, 109-116.
23. McLellan, A. C., Thornalley, P. J., Benn, J., Sonksen, P. H., Glyoxlase system in clinical diabetes mellitus and correlation with diabetic complications, Clin. Sci. 1994, 87, 21-29.
24. Frye, E. B., Degenhardt, T. P., Thrope, S. R., Role of the Maillard reaction in aging of tissue proteins, J. Biol. Chem. 1998, 273, 18714-18719.
25. Vermes, I., Haanen, C., Steffens-Nakken, H., Reutelingsperger, C., A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V, J. Immunol. Methods 1995, 184, 39-51.
26. Yamagishi, S., Nakamura, K., Matsui, T., Advanced glycation end products (AGEs) and their receptor (RAGE) system in diabetic retinopathy, Curr. Drug Discov. Technol. 2006, 6, 83-88.
27. Yagihashi, S., Diabetic neuropathy, Nippon Rinsho. 2006, 3, 155-160.
28. Kurowski, R., Mantitus, J., Advanced glycation end products (AGEs) and renal failure, Przeql. Lek. 2006, 63, 203-208.
29. Munch, G., Thome, J., AGE's in aging and Alzheimer's disease, Brain Res. Rev. 1997, 23, 134-143.
30. Kang, Y., Edwards, L. G., Thornalley, P. J., Effect of methylglyoxal on human leukaemia 60 cell growth: modification of DNA G1 growth arrest and induction of apoptosis, Leuk. Res. 1996, 20, 397-405.
31. Kajstura, J., Bolli, R., Sonnenblick, E. H., Anversa, P., et al., Cause of death: suicide, J. Mol. Cell. Cardio. 2006, 40, 425-437.
32. Ly, J. D., Grubb, D. R., Lawen, A., The mitochondrial membrane potential (deltapsi(m)) in apoptosis; an update. Apoptosis: An International Journal on Programmed Cell Death, Apoptosis 2003, 8, 115-128.
33. Li, Y. H., Gong, P. L., Neuroprotective effects of dauricine against apoptosis induced by transient focal cerebral ischaemia in rats via a mitochondrial pathway, Clin. Exp. Pharmacol. Physiol. 2007, 34, 177-184.
34. Luan, J., Zhou, B., Qi, Z., Tolerance of mice to lipopolysaccharide is correlated with inhibition of caspase-3-mediated apoptosis in mouse liver cells, Acta Biochem. Biophys. Sin. 2007, 39, 96-100.
35. Scorrano, L., Korsmeyer, S. J., Mechanisms of cytochrome c release by proapoptotic BCL-2 family members, Biochem. Biophys. Res. Commun. 2003, 304, 437-444.
36. Seger, R., Krebs, E. G., The MAPK signaling cascade, FASEB J. 1995, 9, 726-735.
37. Cross, T. G., Scheel-Toellner, D., Henriquez, N. V., Deacon, E. et al., Serine/threonine protein kinases and apoptosis, Exp. Cell Res. 2000, 256, 34-41.
38. Franklin, R. A., McCubrey, J. A., Kinase: positive and negative regulators of apoptosis. Leukemia, Leukemia. 2002, 14, 2019-2034.